Over time, the cholinergic hypothesis was expanded to include butyrylcholinesterase (BChE), based on findings that AChE activity decreases in the cortex of AD patients as the disease progresses, while BChE activity remains constant or increases up to 120%, assuming a more prominent role in ACh hydrolysis [7]. This evidence concerns the gene ACHE and Alzheimer disease.